Delivery Order SPE2DX22D0040-SPE2D825FA9MR
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $57,029.60 by the Defense Logistics Agency's Medical Supply Chain. The contract, issued on July 28, 2025, with an ultimate completion date of July 29, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. This award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $82,029.40 by the Defense Logistics Agency's Medical Supply Chain on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,791.30 by the Defense Logistics Agency's Medical Supply Chain on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $36,862.85 by the Defense Logistics Agency's Medical Supply Chain on July 21, 2025, with a completion date of July 22, 2025. This firm fixed price delivery order was awarded without a set-aside designation through competitive procurement procedures. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $43,621.00 by the Defense Logistics Agency's Medical Supply Chain on July 30, 2025. This competitively awarded, firm fixed-price contract is classified as a non-set-aside procurement and is expected to be completed by July 31, 2025. The delivery order represents a continuation of AmerisourceBergen's extensive partnership with the Defense Logistics...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $31,129.52 by the Defense Logistics Agency's Medical Supply Chain on August 2, 2025. This firm fixed-price delivery order, which has an ultimate completion date of August 4, 2025, was competitively awarded with no set-aside designation. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $10,023.75 on July 30, 2025, by the Defense Logistics Agency's Medical Supply Chain. This competitively awarded, firm fixed-price delivery order is non-set-aside and scheduled for completion by July 31, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $84,651.70 by the Defense Logistics Agency's Medical Supply Chain on July 21, 2025, with an ultimate completion date of July 22, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a continuation of the vendor's extensive role in federal pharmaceutical procurement. The contract is issued...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,407.52 by the Defense Logistics Agency's Medical Supply Chain on July 31, 2025. The contract is a firm fixed price, non-set-aside award with an ultimate completion date of August 1, 2025, and represents a child contract under a larger indefinite delivery vehicle. This delivery order is issued under AmerisourceBergen's existing Indefinite...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,774.15 by the Defense Logistics Agency's Medical Supply Chain on August 1, 2025, with an ultimate completion date of August 4, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- SPE2DX22D0040Indefinite Delivery Contract
- SPE2DX22D0040-SPE2D825FA9MRDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $39,022.02 by the Defense Logistics Agency's Medical Supply Chain. The contract, awarded August 4, 2025, with an ultimate completion date of August 5, 2025, represents a firm fixed-price procurement with no set-aside designation. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as the company's primary vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs worldwide. The delivery order procurement is part of the Defense Logistics Agency's broader pharmaceutical distribution strategy, which supports the Defense Health Agency and other federal healthcare systems. AmerisourceBergen's contract portfolio demonstrates capability across a comprehensive range of medical commodities, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. As a competitively awarded non-set-aside contract, this delivery order reflects the contractor's established capability to meet federal procurement requirements and aligns with the DLA's planned Pharmaceutical Prime Vendor Global Program Generation V initiatives, which are structured to make multiple awards across separate geographic regions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $39.0k | 8/4/25 |